脉络宁口服液联合甲钴胺片治疗老年糖尿病周围神经病变的疗效

发布时间：2018-03-23 20:50

本文选题：糖尿病周围神经病变　切入点：脉络宁口服液　出处：《临床神经病学杂志》2017年02期

【摘要】：目的观察脉络宁口服液联合甲钴胺片治疗老年糖尿病周围神经病变(DPN)的疗效。方法将49例DPN患者随机分为治疗组(n=24)和对照组(n=25)。两组患者均采用甲钴胺片治疗,治疗组加用脉络宁口服液,两组均治疗3个月。比较两组患者的多伦多临床评分系统(TCSS)评分、中医症状量化评分。根据中医症状量化评分标准判断患者疗效。结果两组患者治疗后TCSS评分均明显低于治疗前(均P0.05)。治疗组患者治疗后的TCSS评分明显低于对照组(P0.05)。治疗组治疗后中医症状量化评分明显低于治疗前(P0.05)。治疗组治疗后中医症状量化评分明显低于对照组(P0.05)。治疗组患者总有效率(88%)明显高于对照组(50%)(χ~2=6.631,P=0.01)。结论脉络宁口服液联合甲钴胺片对DPN治疗安全有效。
[Abstract]:Objective to observe the efficacy of Mailuoning oral liquid combined with mecobalamin tablets in the treatment of diabetic peripheral neuropathy in elderly patients. Methods 49 patients with DPN were randomly divided into two groups: treatment group (n = 49) and control group (n = 25). The treatment group was treated with Mailuoning oral liquid for 3 months. The TCSS scores of the two groups were compared. Results the TCSS scores of the two groups after treatment were significantly lower than those before treatment (all P 0.05). The TCSS score of the patients in the treatment group was significantly lower than that in the control group after treatment. After treatment, the quantitative score of TCM symptoms in the treatment group was significantly lower than that in the control group (P 0.05). The total effective rate of the treatment group was significantly higher than that of the control group. Liquid and mecobalamin tablets are safe and effective in the treatment of DPN.
【作者单位】：江苏省南京市点将台社会福利院(南京安宁医院)内科;
【分类号】：R587.2

【相似文献】